​

Funding Round

Seed Round - Taysha Gene Therapies

Seed Round - Taysha Gene Therapies

Investment Firm

Overview

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Announced Date

Apr 29, 2020

Funding Type

Seed

Highlights

Location

United States, North America

Social

Investor Lead

Nolan Capital

Nolan Capital

Nolan Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

PBM Capital Group

PBM Capital Group

PBM Capital Group is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

2

Investor Name
Participant InvestorPBM Capital Group
Participant InvestorNolan Capital

Round Details and Background

Taysha Gene Therapies raised $30000000 on 2020-04-29 in Seed Round

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 03, 2022
Post-IPO Equity - Taysha Gene Therapies
-3.0M
Aug 14, 2023
Post-IPO Equity - Taysha Gene Therapies
11-150.0M
Dec 19, 2023
Post-IPO Debt - Taysha Gene Therapies
1-40.0M
Jun 26, 2024
Post-IPO Equity - Taysha Gene Therapies
-75.0M

Recent Activity

There is no recent news or activity for this profile.